Answers are grounded in this paper and cite their sources.
Plasma CRP concentration, in the presence of a major exacerbation symptom, is useful in the confirmation of COPD exacerbation. Systemic biomarkers were not helpful in predicting exacerbation severity. The acute-phase response at exacerbation was most strongly related to indices of monocyte function.
No takes yet. Share an insight, caveat, or question.
Hurst et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: